Janus Global Life Sciences Fund (JAGLX)

Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 7/28/15 )$65.50
Total Net Assets (As of 6/30/15)$4.99B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 6/30/15)
1 Year40.08%
3 Year39.10%
5 Year31.38%
10 Year15.39%
Morningstar (As of 6/30/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

123 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

PERFORMANCE View Time Period:
As of 7/28/15As of 6/30/15As of 6/30/15As of 6/30/15
Inception: Dec 31, 1998
PRICE1 DAY
RETURN

YTD
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Class T Shares 
$65.501.77%24.71%40.08%39.10%31.38%15.39%13.24%40.08%39.10%31.38%15.39%13.24%40.08%169.13%291.48%318.57%677.49%
MSCI World Health Care Index12.05%
(07/27/2015)
17.19%24.10%20.85%10.16%6.41%17.19%24.10%20.85%10.16%6.41%17.19%91.14%157.75%163.25%178.67%
S&P 500® Index1.55%
(07/27/2015)
7.42%17.31%17.34%7.89%5.14%7.42%17.31%17.34%7.89%5.14%7.42%61.43%122.47%113.77%128.49%

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.

Annual Expense Ratio: Gross: 0.93% / Net: 0.93% View Fees and Expenses

RISK STATISTICS
VS. MSCI World Health Care Index

VIEW RISK STATISTICS DEFINITIONS

Alpha
Compares the risk-adjusted performance of a portfolio to a benchmark index.
Beta
A measure of the volatility of a portfolio in comparison to a benchmark index.
R-Squared
Represents the percentage of the portfolio’s performance that can be explained by the general movements of a benchmark index.
Standard Deviation
Measures historical volatility.
Sharpe Ratio
Measures risk-adjusted performance by dividing the portfolio’s excess returns by the standard deviation of those returns.
Information Ratio
Measure of a portfolio management’s performance against risk and return relative to a benchmark or alternative measure.
FUNDINDEX
Alpha10.668.59N/AN/A
Beta1.081.031.001.00
R-Squared (%)56.7667.40100.00100.00
Standard Deviation12.4612.988.6610.37
Sharpe Ratio3.132.412.782.00
Information Ratio1.821.42----

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

MORNINGSTAR PERCENTILEView Time Period:
As of 6/30/15As of 6/30/15
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Percentile Ranking (%)25112228212511222821
Health Category
Rank/Count
34 / 13214 / 12728 / 12634 / 12015 / 7034 / 13214 / 12728 / 12634 / 12015 / 70

CALENDAR YEAR PERFORMANCE

GROWTH OF A $10,000 HYPOTHETICAL INVESTMENT

UP AND DOWN MARKET CAPTURE

AS OF 6/30/153 YR UP MARKET
CAPTURE
3 YR DOWN MARKET
CAPTURE
5 YR UP MARKET
CAPTURE
5 YR DOWN MARKET
CAPTURE
Janus Global Life Sciences Fund149.63%74.31%135.17%88.78%
MSCI World Health Care Index100.00%100.00%100.00%100.00%

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

ANNUAL FEES & EXPENSES

AS OF FISCAL YEAR END 9/30/2014
CLASS T SHARES
Management Fees0.64%
12b-1 FeesN/A
Other Expenses0.29%
Total Gross Expenses0.93%
WaiversN/A
TOTAL NET EXPENSES0.93%